In the BioHarmony Drug Report Database
Danazol
Danocrine (danazol) is a small molecule pharmaceutical. Danazol was first approved as Danocrine on 1982-01-01. It is used to treat endometriosis and fibrocystic breast disease in the USA. The pharmaceutical is active against androgen receptor.
Trade Name
|
Danocrine |
|---|---|
Common Name
|
danazol |
ChEMBL ID
|
CHEMBL1479 |
Indication
|
endometriosis, fibrocystic breast disease |
Drug Class
|
Androgen; Anabolic steroid; Progestogen; Progestin; Antigonadotropin; Steroidogenesis inhibitor; Antiestrogen |
Image (chem structure or protein)